comparemela.com

Latest Breaking News On - Ultragenyx pharmaceutical inc - Page 8 : comparemela.com

Ultragenyx Pharmaceutical (NASDAQ:RARE) Now Covered by Royal Bank of Canada

Ultragenyx Pharmaceutical (NASDAQ:RARE) Now Covered by Royal Bank of Canada
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China
Canada
Japan
United-states
America
Robertw-baird
Thomas-richard-kassberg
Canaccord-genuity-group
Royal-bank
Nasdaq
China-universal-asset-management-co
Cantor-fitzgerald

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06

Form DEF 14A Amylyx Pharmaceuticals, For: Jun 06
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada
Netherlands
Malvern
Worcestershire
United-kingdom
United-states
Cambridge
Cambridgeshire
Harvard-university
Massachusetts
Boston
California

TD Cowen Boosts Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $61.00

TD Cowen Boosts Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $61.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Japan
Canada
China
United-states
America
Robertw-baird
Thomas-richard-kassberg
Cantor-fitzgerald
China-universal-asset-management-co
Ultragenyx-pharmaceutical-inc
Canaccord-genuity-group
Securities-exchange-commission

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Raised to $61.00 at TD Cowen

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target Raised to $61.00 at TD Cowen
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states
Japan
Canada
America
Thomas-richard-kassberg
Robertw-baird
Royal-bank
Associates-corp
Securities-exchange-commission
International-assets-investment-management
Covestor-ltd
Cantor-fitzgerald

Buy this little-known pharma stock with more than 80% upside: RBC

Analyst Luca Issi began research coverage of the pharmaceutical company, which develops treatments for rare and ultra-rare diseases, with an outperform rating.

Drug-administration
Ultragenyx-pharmaceutical
Analyst-luca-issi
Osteogenesis-imperfecta
Ultragenyx-pharmaceutical-inc
Stock-markets
Investment-strategy
Business-news

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.